• Obeticholic Acid in FXR Liver Research

  2026-09-11

  Obeticholic Acid provides a selective FXR-centered way to connect bile acid homeostasis with cholestasis, inflammation, and fibrosis assays. This practical guide combines hepatocyte gene-regulation workflows with translational study design informed by a 2025 liver-fibrosis paper, while separating established product biology from exploratory applications.

• Parathyroid hormone (1-34) (human) in VC Research

  2026-09-11

  Parathyroid hormone (1-34) (human) provides a defined receptor-active perturbation for connecting calcium biology with endothelial-to-mesenchymal transition and valvular calcification studies. This guide shows how to build concentration-response assays, CKD-relevant endothelial workflows, and bone metabolism experiments while avoiding common peptide-handling and interpretation errors.

• Methoxy-X04 Workflow for Amyloid Imaging

  2026-09-10

  Use Methoxy-X04 to connect plaque burden, cerebrovascular amyloid, and microglial clearance in Alzheimer’s disease models. This workflow combines rapid brain-accessible imaging with experimental controls that help distinguish true amyloid changes from staining, timing, and optical artifacts.

• PF-573228: A FAK Inhibitor for Mechanistic Studies

  2026-09-10

  PF-573228 is an ATP-competitive FAK inhibitor used to study focal-adhesion signaling, cancer-cell behavior, endothelial responses, and mechanotransduction. Its reported biochemical potency is 4 nM, but cellular responses require assay-specific dose and vehicle controls.

• GSTA1 Drives α-Amanitin Liver Toxicity

  2026-09-09

  The reference study identifies GSTA1 as an unexpected driver of α-amanitin hepatotoxicity: NRF2-dependent GSTA1 upregulation accelerates glutathione depletion rather than protecting hepatocytes. By integrating mouse toxicology, multi-omics, protein-interaction assays, and genetic perturbation, the work proposes GSTA1 as a mechanistic target and candidate biomarker for amatoxin-related liver injury.

• Minoxidil sulphate: Vascular Research Workflows

  2026-09-09

  Use Minoxidil sulphate as an activation-side probe for potassium-channel and vasodilation studies, while keeping renal perfusion, tissue state, and vehicle effects experimentally separate. This workflow also shows how the compound can support hair follicle and alopecia research without overextending vascular findings into clinical claims.

• Aclacinomycin A for rDNA Damage Workflows

  2026-09-08

  Aclacinomycin A, also called Aclarubicin, supports more than endpoint cytotoxicity assays: it can connect topological stress, persistent ribosomal-DNA lesions, PML-nucleolar responses, and apoptosis. This practical workflow separates early DNA damage from later caspase signaling, necrosis, and proteasome-related confounding.

• Sodium Picosulfate in Gut–Brain Research

  2026-09-07

  Sodium Picosulfate offers a controllable way to study intestinal water and electrolyte handling, stool phenotypes, and gut–liver–brain interactions in research models. This workflow connects constipation assays with region-resolved neuroinflammation imaging while clearly separating validated findings from exploratory applications.

• Methoxy-X04 and the Next Era of Amyloid Imaging

  2026-09-07

  Methoxy-X04 offers a brain-permeable route to visualizing amyloid pathology while connecting plaque burden with emerging biology around exercise-induced extracellular vesicles and microglial clearance. This thought-leadership perspective outlines how translational researchers can use a fluorescent amyloid beta probe to build more informative, mechanism-aware Alzheimer’s disease studies.

• FXR–Fibrosis Biology: Translational Lessons for MASLD

  2026-09-05

  Obeticholic Acid provides a mechanistically defined FXR platform for connecting bile acid homeostasis, hepatic inflammation, portal pressure, and metabolic dysfunction with emerging 11β-HSD1, Notch, and NK-cell findings in liver fibrosis research.

• ETS1–SENP2 Axis in BPD Mitophagy

  2026-09-04

  The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation, HSPA8 binding, and FUNDC1 degradation. Its findings distinguish protective suppression of excessive mitophagy from nonspecific autophagy inhibition and provide a mechanistic framework for studying mitochondrial quality control in developing lung tissue.

• Deferasirox and Ferritinophagy in Stress Assays

  2026-09-04

  Deferasirox is an oral iron chelator with a useful, but often underappreciated, role in dissecting how iron availability intersects with lysosomal stress. This article translates new TCF25–ferritinophagy findings into more rigorous assay designs while separating established mechanisms from testable cancer biology hypotheses.

• Tauroursodeoxycholic Acid in Autophagy Workflows

  2026-09-04

  Tauroursodeoxycholic Acid (TUDCA) provides a practical chemical-chaperone intervention for separating ER stress, apoptosis, mitochondrial injury, and autophagy defects in metabolic models. This workflow connects TUDCA treatment with the Galectin-1–FIP200 mechanism reported in hepatic steatosis while emphasizing controls that prevent overinterpretation.

• Saquinavir Workflows for HIV Protease Research

  2026-09-03

  Build more informative Saquinavir experiments by pairing HIV protease inhibition assays with biomimetic membrane-partition measurements. This workflow shows when to select IAM liquid chromatography or LEKC, how to control solvent and stability variables, and how to interpret permeability data without conflating membrane behavior with antiviral target engagement.

• FLOT1–FOSL2–EphA2 Signaling in Alzheimer’s Disease

  2026-09-02

  A 2026 Neuropharmacology study identifies a FLOT1–FOSL2–EphA2 regulatory axis that drives pro-inflammatory microglial polarization through p38/MAPK signaling in an APP/PS1 model. The findings connect a lipid-raft-associated scaffold protein to transcriptional control and suggest a mechanistically testable route for reducing neuroinflammation and cognitive decline.

7885 records 1/526 page Next 12345 下5页 Last page